89 related articles for article (PubMed ID: 16801081)
1. Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia.
Elisaf M; Karabina SA; Bairaktari E; Goudevenos JA; Siamopoulos KC; Tselepis AD
Platelets; 1999; 10(2-3):124-31. PubMed ID: 16801081
[TBL] [Abstract][Full Text] [Related]
2. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
3. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
[TBL] [Abstract][Full Text] [Related]
5. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
7. Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes.
Gomes MB; Cobas RA; Nunes E; Nery M; Castro-Faria-Neto HC; Tibiriçá E
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):42-6. PubMed ID: 18718550
[TBL] [Abstract][Full Text] [Related]
8. The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable angina.
Tanaseanu C; Moldoveanu E; Kosaka T; Tanaseanu S; Neagu M; Popescu LM
Eur J Intern Med; 2004 Aug; 15(5):291-297. PubMed ID: 15450986
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
[TBL] [Abstract][Full Text] [Related]
10. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
[TBL] [Abstract][Full Text] [Related]
11. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits.
Karantonis HC; Antonopoulou S; Perrea DN; Sokolis DP; Theocharis SE; Kavantzas N; Iliopoulos DG; Demopoulos CA
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):174-85. PubMed ID: 16580585
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.
Goudevenos J; Tselepis AD; Tsoukatos D; Grekas G; Kritikakos J; Sideris D
Eur Heart J; 1995 Aug; 16(8):1036-43. PubMed ID: 8665964
[TBL] [Abstract][Full Text] [Related]
13. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
14. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
Karantonis HC; Fragopoulou E; Antonopoulou S; Rementzis J; Phenekos C; Demopoulos CA
Diabetes Res Clin Pract; 2006 Apr; 72(1):33-41. PubMed ID: 16236380
[TBL] [Abstract][Full Text] [Related]
15. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
[TBL] [Abstract][Full Text] [Related]
16. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
[TBL] [Abstract][Full Text] [Related]
18. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
[TBL] [Abstract][Full Text] [Related]
19. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
[TBL] [Abstract][Full Text] [Related]
20. Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia.
Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Miltiadous G; Goudevenos JA; Cariolou MA; Chapman MJ; Tselepis AD; Elisaf M
J Lipid Res; 2002 Feb; 43(2):256-63. PubMed ID: 11861667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
